Mingming Zhao, Ph.D. - Publications
Affiliations: | 2003 | Stony Brook University, Stony Brook, NY, United States |
Area:
Molecular Biology, Cell Biology, Biochemistry, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Zhao M, Janas JA, Niki M, Pandolfi PP, Van Aelst L. Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Molecular and Cellular Biology. 26: 2479-89. PMID 16537894 DOI: 10.1128/Mcb.26.7.2479-2489.2006 | 0.605 | |||
2004 | Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. Role of Dok-1 and Dok-2 in leukemia suppression. The Journal of Experimental Medicine. 200: 1689-95. PMID 15611295 DOI: 10.1084/Jem.20041306 | 0.595 | |||
2004 | Niki M, Di Cristofano A, Zhao M, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. Critical Role of Dok-1 and Dok-2 in Leukemia Suppression. Blood. 104: 2951-2951. DOI: 10.1182/Blood.V104.11.2951.2951 | 0.433 | |||
2002 | Zhu JJ, Qin Y, Zhao M, Van Aelst L, Malinow R. Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell. 110: 443-55. PMID 12202034 DOI: 10.1016/S0092-8674(02)00897-8 | 0.531 | |||
2001 | Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). The Journal of Experimental Medicine. 194: 275-84. PMID 11489947 DOI: 10.1084/Jem.194.3.275 | 0.598 | |||
2001 | Zhao M, Schmitz AA, Qin Y, Di Cristofano A, Pandolfi PP, Van Aelst L. Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. The Journal of Experimental Medicine. 194: 265-74. PMID 11489946 DOI: 10.1084/Jem.194.3.265 | 0.596 | |||
Show low-probability matches. |